# Builders FirstSource, Inc.: financial statements, quarterly

BLDR · NYSE · CIK 1316835 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bldr.md) · [Financials](/companies/bldr/financials.md) · [Filings](/companies/bldr/filings.md) · [Insiders](/companies/bldr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bldr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,534](/filings/0000950170-24-121436.md) | [4,151 d](/filings/0001193125-26-054643.md) | [3,891](/filings/0000950170-25-061689.md) | [4,456](/filings/0000950170-25-100705.md) | [4,232](/filings/0001193125-25-257970.md) | [3,820 d](/filings/0001193125-26-054643.md) | [3,657](/filings/0001193125-26-195140.md) | [4,234](/filings/0001193125-26-325451.md) | [3,941](/filings/0001193125-25-257970.md) | [3,358 d](/filings/0001193125-26-054643.md) | [3,287](/filings/0001193125-26-195140.md) | [3,863](/filings/0001193125-26-325451.md) |
| Cost of revenue | $m | [2,953](/filings/0000950170-24-121436.md) | [2,686 d](/filings/0001193125-26-054643.md) | [2,591](/filings/0000950170-25-061689.md) | [2,994](/filings/0000950170-25-100705.md) | [2,846](/filings/0001193125-25-257970.md) | [2,586 d](/filings/0001193125-26-054643.md) | [2,542](/filings/0001193125-26-195140.md) | [2,935](/filings/0001193125-26-325451.md) | [2,742](/filings/0001193125-25-257970.md) | [2,356 d](/filings/0001193125-26-054643.md) | [2,358](/filings/0001193125-26-195140.md) | [2,776](/filings/0001193125-26-325451.md) |
| Gross profit | $m | [1,581](/filings/0000950170-24-121436.md) | [1,465 d](/filings/0001193125-26-054643.md) | [1,300](/filings/0000950170-25-061689.md) | [1,463](/filings/0000950170-25-100705.md) | [1,386](/filings/0001193125-25-257970.md) | [1,234 d](/filings/0001193125-26-054643.md) | [1,115](/filings/0001193125-26-195140.md) | [1,299](/filings/0001193125-26-325451.md) | [1,199](/filings/0001193125-25-257970.md) | [1,002 d](/filings/0001193125-26-054643.md) | [929](/filings/0001193125-26-195140.md) | [1,087](/filings/0001193125-26-325451.md) |
| Selling, general and administrative | $m | [939](/filings/0000950170-24-121436.md) | [974 d](/filings/0001193125-26-054643.md) | [926](/filings/0000950170-25-061689.md) | [973](/filings/0000950170-25-100705.md) | [958](/filings/0001193125-25-257970.md) | [930 d](/filings/0001193125-26-054643.md) | [931](/filings/0001193125-26-195140.md) | [988](/filings/0001193125-26-325451.md) | [971](/filings/0001193125-25-257970.md) | [940 d](/filings/0001193125-26-054643.md) | [912](/filings/0001193125-26-195140.md) | [958](/filings/0001193125-26-325451.md) |
| Operating income | $m | [642](/filings/0000950170-24-121436.md) | [490 d](/filings/0001193125-26-054643.md) | [374](/filings/0000950170-25-061689.md) | [489](/filings/0000950170-25-100705.md) | [428](/filings/0001193125-25-257970.md) | [304 d](/filings/0001193125-26-054643.md) | [184](/filings/0001193125-26-195140.md) | [311](/filings/0001193125-26-325451.md) | [229](/filings/0001193125-25-257970.md) | [61.8 d](/filings/0001193125-26-054643.md) | [16.5](/filings/0001193125-26-195140.md) | [129](/filings/0001193125-26-325451.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [140](/filings/0000950170-24-121436.md) | [92.9 d](/filings/0001193125-26-054643.md) | [66.5](/filings/0000950170-25-061689.md) | [93.4](/filings/0000950170-25-100705.md) | [89.0](/filings/0001193125-25-257970.md) | [60.8 d](/filings/0001193125-26-054643.md) | [23.2](/filings/0001193125-26-195140.md) | [54.3](/filings/0001193125-26-325451.md) | [37.1](/filings/0001193125-25-257970.md) | [(37.5) d](/filings/0001193125-26-054643.md) | [(10.5)](/filings/0001193125-26-195140.md) | [56.3](/filings/0001193125-26-325451.md) |
| Net income | $m | [451](/filings/0000950170-24-121436.md) | [351 d](/filings/0001193125-26-054643.md) | [259](/filings/0001193125-25-257970.md) | [344](/filings/0001193125-25-257970.md) | [285](/filings/0001193125-25-257970.md) | [190 d](/filings/0001193125-26-054643.md) | [96.3](/filings/0001193125-26-325451.md) | [185](/filings/0001193125-26-325451.md) | [122](/filings/0001193125-25-257970.md) | [31.5 d](/filings/0001193125-26-054643.md) | [(47.4)](/filings/0001193125-26-325451.md) | [(3.9)](/filings/0001193125-26-325451.md) |
| Diluted EPS | $ per share | [3.59](/filings/0000950170-24-121436.md) | not reported | [2.10](/filings/0000950170-25-061689.md) | [2.87](/filings/0000950170-25-100705.md) | [2.44](/filings/0001193125-25-257970.md) | not reported | [0.84](/filings/0001193125-26-195140.md) | [1.66](/filings/0001193125-26-325451.md) | [1.10](/filings/0001193125-25-257970.md) | not reported | [(0.43)](/filings/0001193125-26-195140.md) | [(0.04)](/filings/0001193125-26-325451.md) |
| Basic EPS | $ per share | [3.62](/filings/0000950170-24-121436.md) | not reported | [2.12](/filings/0000950170-25-061689.md) | [2.89](/filings/0000950170-25-100705.md) | [2.45](/filings/0001193125-25-257970.md) | not reported | [0.85](/filings/0001193125-26-195140.md) | [1.67](/filings/0001193125-26-325451.md) | [1.11](/filings/0001193125-25-257970.md) | not reported | [(0.43)](/filings/0001193125-26-195140.md) | [(0.04)](/filings/0001193125-26-325451.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000950170-23-057261.md) | [0.1](/filings/0000950170-25-023953.md) | [0.7](/filings/0000950170-24-054249.md) | [0.1](/filings/0000950170-24-091788.md) | [0.3](/filings/0000950170-24-121436.md) | [0.2](/filings/0001193125-26-054643.md) | [0.1](/filings/0000950170-25-061689.md) | [0.1](/filings/0000950170-25-100705.md) | [0.3](/filings/0001193125-25-257970.md) | [0.2](/filings/0001193125-26-325451.md) | [0.1](/filings/0001193125-26-195140.md) | [0.1](/filings/0001193125-26-325451.md) |
| Current assets | $bn | [3.6](/filings/0000950170-23-057261.md) | [3.3](/filings/0000950170-25-023953.md) | [3.9](/filings/0000950170-24-054249.md) | [3.5](/filings/0000950170-24-091788.md) | [3.5](/filings/0000950170-24-121436.md) | [3.1](/filings/0001193125-26-054643.md) | [3.3](/filings/0000950170-25-061689.md) | [3.3](/filings/0000950170-25-100705.md) | [3.3](/filings/0001193125-25-257970.md) | [2.9](/filings/0001193125-26-325451.md) | [3.1](/filings/0001193125-26-195140.md) | [3.2](/filings/0001193125-26-325451.md) |
| Total assets | $bn | [10.7](/filings/0000950170-23-057261.md) | [10.5](/filings/0000950170-25-023953.md) | [11.2](/filings/0000950170-24-054249.md) | [10.7](/filings/0000950170-24-091788.md) | [10.9](/filings/0000950170-24-121436.md) | [10.6](/filings/0001193125-26-054643.md) | [11.4](/filings/0000950170-25-061689.md) | [11.5](/filings/0000950170-25-100705.md) | [11.4](/filings/0001193125-25-257970.md) | [11.2](/filings/0001193125-26-325451.md) | [11.3](/filings/0001193125-26-195140.md) | [11.3](/filings/0001193125-26-325451.md) |
| Current liabilities | $bn | [2.0](/filings/0000950170-23-057261.md) | [1.9](/filings/0000950170-25-023953.md) | [1.8](/filings/0000950170-24-054249.md) | [1.9](/filings/0000950170-24-091788.md) | [2.0](/filings/0000950170-24-121436.md) | [1.8](/filings/0001193125-26-054643.md) | [1.8](/filings/0000950170-25-061689.md) | [1.8](/filings/0000950170-25-100705.md) | [1.8](/filings/0001193125-25-257970.md) | [1.6](/filings/0001193125-26-325451.md) | [1.8](/filings/0001193125-26-195140.md) | [1.8](/filings/0001193125-26-325451.md) |
| Total liabilities | $bn | [6.2](/filings/0000950170-23-057261.md) | [5.8](/filings/0000950170-25-023953.md) | [6.2](/filings/0000950170-24-054249.md) | [6.4](/filings/0000950170-24-091788.md) | [6.4](/filings/0000950170-24-121436.md) | [6.3](/filings/0001193125-26-054643.md) | [7.1](/filings/0000950170-25-061689.md) | [7.3](/filings/0000950170-25-100705.md) | [7.1](/filings/0001193125-25-257970.md) | [6.9](/filings/0001193125-26-325451.md) | [7.3](/filings/0001193125-26-195140.md) | [7.3](/filings/0001193125-26-325451.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.6](/filings/0000950170-24-121436.md) | [4.7](/filings/0001193125-26-054643.md) | [5.0](/filings/0001193125-25-257970.md) | [4.3](/filings/0001193125-25-257970.md) | [4.4](/filings/0001193125-25-257970.md) | [4.3](/filings/0001193125-26-325451.md) | [4.4](/filings/0001193125-26-325451.md) | [4.2](/filings/0001193125-26-325451.md) | [4.3](/filings/0001193125-25-257970.md) | [4.4](/filings/0001193125-26-325451.md) | [4.0](/filings/0001193125-26-325451.md) | [4.0](/filings/0001193125-26-325451.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [649 d](/filings/0000950170-24-121436.md) | [612 d](/filings/0001193125-26-054643.md) | [317](/filings/0000950170-25-061689.md) | [452 d](/filings/0000950170-25-100705.md) | [730 d](/filings/0001193125-25-257970.md) | [373 d](/filings/0001193125-26-054643.md) | [132](/filings/0001193125-26-195140.md) | [341 d](/filings/0001193125-26-325451.md) | [548 d](/filings/0001193125-25-257970.md) | [195 d](/filings/0001193125-26-054643.md) | [87.5](/filings/0001193125-26-195140.md) | [68.0 d](/filings/0001193125-26-325451.md) |
| Capital expenditure | $m | [145 d](/filings/0000950170-24-121436.md) | [99.7 d](/filings/0001193125-26-054643.md) | [93.2](/filings/0000950170-25-061689.md) | [88.1 d](/filings/0000950170-25-100705.md) | [99.6 d](/filings/0001193125-25-257970.md) | [99.7 d](/filings/0001193125-26-054643.md) | [100.0](/filings/0001193125-26-195140.md) | [88.7 d](/filings/0001193125-26-325451.md) | [85.8 d](/filings/0001193125-25-257970.md) | [88.1 d](/filings/0001193125-26-054643.md) | [46.7](/filings/0001193125-26-195140.md) | [38.0 d](/filings/0001193125-26-325451.md) |
| Share repurchases | $m | [210 d](/filings/0000950170-24-121436.md) | [219 d](/filings/0001193125-26-054643.md) | [16.8](/filings/0000950170-25-061689.md) | [983 d](/filings/0000950170-25-100705.md) | [153 d](/filings/0001193125-25-257970.md) | [364 d](/filings/0001193125-26-054643.md) | [12.3](/filings/0001193125-26-195140.md) | [402 d](/filings/0001193125-26-325451.md) | [0.0 d](/filings/0001193125-25-257970.md) | [0.0 d](/filings/0001193125-26-054643.md) | [300](/filings/0001193125-26-195140.md) | [3.5 d](/filings/0001193125-26-325451.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [156](/filings/0000950170-23-057261.md) | [138](/filings/0000950170-24-054249.md) | [128](/filings/0000950170-24-091788.md) | [126](/filings/0000950170-24-121436.md) | [123](/filings/0000950170-25-061689.md) | [120](/filings/0000950170-25-100705.md) | [117](/filings/0001193125-25-257970.md) | [114](/filings/0001193125-26-195140.md) | [111](/filings/0001193125-26-325451.md) | [111](/filings/0001193125-25-257970.md) | [110](/filings/0001193125-26-195140.md) | [108](/filings/0001193125-26-325451.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 107,596,457 at 2026-07-23, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-325451.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.